Erlotinib after failure of gefitinib treatment of more than 6 months in advanced non-small cell lung cancer.
Kyoichi
K
Kaira
Nobuyuki
N
Yamamoto
D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis*; D000069347:Erlotinib Hydrochloride; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000008:administration & dosage*
D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D000077156:Gefitinib